Cargando…

537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE)

BACKGROUND: Active surveillance testing (AST) for Carbapenem-resistant Enterobacteriaceae (CRE) to identify and isolate asymptomatic carriers has been recommended to help prevent patient to patient transmission. Optimal screening population, frequency, and testing method remain a subject of debate....

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Eileen, Kester, Shelley, Layell, Jessica, Neelakanta, Anupama, Capraro, Gerald A, Passaretti, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811096/
http://dx.doi.org/10.1093/ofid/ofz360.606
_version_ 1783462397369909248
author Campbell, Eileen
Kester, Shelley
Layell, Jessica
Neelakanta, Anupama
Capraro, Gerald A
Passaretti, Catherine
author_facet Campbell, Eileen
Kester, Shelley
Layell, Jessica
Neelakanta, Anupama
Capraro, Gerald A
Passaretti, Catherine
author_sort Campbell, Eileen
collection PubMed
description BACKGROUND: Active surveillance testing (AST) for Carbapenem-resistant Enterobacteriaceae (CRE) to identify and isolate asymptomatic carriers has been recommended to help prevent patient to patient transmission. Optimal screening population, frequency, and testing method remain a subject of debate. METHODS: Beginning in 2012, all clinical cultures yielding a CRE isolate in an 898-bed teaching hospital were reviewed to determine whether the isolate was hospital-acquired (HA). HA CRE rates per 10,000 patient-days were calculated. From 1/2013 to 6/2015, in-house, culture-based point prevalence surveys were performed on rectal swabs from rotating units using the CDC recommended method. 7/2015 through 8/2016, culture-based AST was outsourced to a reference laboratory and AST was expanded to include high-risk patients on admission with weekly sweeps on high-risk units. Of note, revised CLSI breakpoints were implemented by our laboratory in 7/2016, which resulted in an increase in CRE detections. Surveillance was suspended from September 2016 to January 2018 when we resumed AST utilizing in-house PCR for KPC, NDM, OXA48, IMP and VIM mechanisms. Rates of HA CRE were compared between surveillance periods. Cohorting of patients in select units, focus on hand hygiene and isolation, antibiotic stewardship, and CHG bathing were ongoing throughout all time periods. RESULTS: 510 rectal swabs in 424 patients were positive for CRE. Additional clinical cultures yielding CRE were absent in 83% of those patients, so would otherwise have gone undetected. Of those patients with both positive AST and clinical culture, 70% had a positive AST result prior to their clinical culture (range 0–997 days, average 94 days, median 14.5 days prior to clinical culture). Compared with preceding periods with no surveillance, on admission and weekly CRE AST, whether utilizing culture based or PCR based screening, was associated with significantly lower rates of HA CRE. (See Table 1). Rates of HA CRE during the initial point prevalence AST period were unchanged compared with periods with no surveillance. Community-onset CRE did not significantly change in any of the time periods monitored (Figure 2). CONCLUSION: On admission and weekly AST was associated with a significant decrease in HA CRE in a large teaching hospital. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6811096
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68110962019-10-28 537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE) Campbell, Eileen Kester, Shelley Layell, Jessica Neelakanta, Anupama Capraro, Gerald A Passaretti, Catherine Open Forum Infect Dis Abstracts BACKGROUND: Active surveillance testing (AST) for Carbapenem-resistant Enterobacteriaceae (CRE) to identify and isolate asymptomatic carriers has been recommended to help prevent patient to patient transmission. Optimal screening population, frequency, and testing method remain a subject of debate. METHODS: Beginning in 2012, all clinical cultures yielding a CRE isolate in an 898-bed teaching hospital were reviewed to determine whether the isolate was hospital-acquired (HA). HA CRE rates per 10,000 patient-days were calculated. From 1/2013 to 6/2015, in-house, culture-based point prevalence surveys were performed on rectal swabs from rotating units using the CDC recommended method. 7/2015 through 8/2016, culture-based AST was outsourced to a reference laboratory and AST was expanded to include high-risk patients on admission with weekly sweeps on high-risk units. Of note, revised CLSI breakpoints were implemented by our laboratory in 7/2016, which resulted in an increase in CRE detections. Surveillance was suspended from September 2016 to January 2018 when we resumed AST utilizing in-house PCR for KPC, NDM, OXA48, IMP and VIM mechanisms. Rates of HA CRE were compared between surveillance periods. Cohorting of patients in select units, focus on hand hygiene and isolation, antibiotic stewardship, and CHG bathing were ongoing throughout all time periods. RESULTS: 510 rectal swabs in 424 patients were positive for CRE. Additional clinical cultures yielding CRE were absent in 83% of those patients, so would otherwise have gone undetected. Of those patients with both positive AST and clinical culture, 70% had a positive AST result prior to their clinical culture (range 0–997 days, average 94 days, median 14.5 days prior to clinical culture). Compared with preceding periods with no surveillance, on admission and weekly CRE AST, whether utilizing culture based or PCR based screening, was associated with significantly lower rates of HA CRE. (See Table 1). Rates of HA CRE during the initial point prevalence AST period were unchanged compared with periods with no surveillance. Community-onset CRE did not significantly change in any of the time periods monitored (Figure 2). CONCLUSION: On admission and weekly AST was associated with a significant decrease in HA CRE in a large teaching hospital. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6811096/ http://dx.doi.org/10.1093/ofid/ofz360.606 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Campbell, Eileen
Kester, Shelley
Layell, Jessica
Neelakanta, Anupama
Capraro, Gerald A
Passaretti, Catherine
537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE)
title 537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE)
title_full 537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE)
title_fullStr 537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE)
title_full_unstemmed 537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE)
title_short 537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE)
title_sort 537. impact of active surveillance testing (ast) on rates of hospital-acquired carbapenem-resistant enterobacteriaceae (cre)
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811096/
http://dx.doi.org/10.1093/ofid/ofz360.606
work_keys_str_mv AT campbelleileen 537impactofactivesurveillancetestingastonratesofhospitalacquiredcarbapenemresistantenterobacteriaceaecre
AT kestershelley 537impactofactivesurveillancetestingastonratesofhospitalacquiredcarbapenemresistantenterobacteriaceaecre
AT layelljessica 537impactofactivesurveillancetestingastonratesofhospitalacquiredcarbapenemresistantenterobacteriaceaecre
AT neelakantaanupama 537impactofactivesurveillancetestingastonratesofhospitalacquiredcarbapenemresistantenterobacteriaceaecre
AT caprarogeralda 537impactofactivesurveillancetestingastonratesofhospitalacquiredcarbapenemresistantenterobacteriaceaecre
AT passaretticatherine 537impactofactivesurveillancetestingastonratesofhospitalacquiredcarbapenemresistantenterobacteriaceaecre